Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jennifer G. Reddan"'
Autor:
Emily Pherson, Todd W. Nesbit, Mary G Petrovskis, Molly Billstein Leber, Heidi A Pillen, Christy Ciccarello, Mandy C. Leonard, Celia A. Proctor, Jennifer G. Reddan
Publikováno v:
American Journal of Health-System Pharmacy. 78:907-918
Publikováno v:
Journal of Pharmacy Practice. 31:408-410
Continual price increases of pharmaceutical products have taken a great toll on pharmacy expenditures. Cost of prescription drugs for the health-care system increased by an average of 11.7% in 2015. In today’s market with ever-increasing drug costs
Autor:
Betsy Vance, Jennifer G. Reddan, Shannon Smallwood, Karen J. Arthur, James Fuller, Therese Staublin, Alana Washington, Todd A Walroth, Tammy Haslar
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 75(12)
Purpose Development and implementation of an interprofessional consensus–driven process for review and optimization of smart-pump drug libraries and dosing limits are described. Summary The Indianapolis Coalition for Patient Safety (ICPS), which re
Autor:
Heather A. Dossett, Jennifer G. Reddan, Meagan Doolin, James Fuller, Todd A. Walroth, Dan Degnan, Derek McMichael
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 74(7)
Purpose A multidisciplinary, consensus-driven initiative to promote the use of standardized medication concentrations for adult drug infusions across the state of Indiana is described. Methods To accomplish development of the Indiana Standard Concent
Publikováno v:
Annals of Pharmacotherapy. 46:634-641
Background: It has been reported that error occurs at some point during the medication use process in approximately 6% of medication doses administered in the inpatient setting. An estimated 1-10% of medication errors lead to patient harm; however, f
Publikováno v:
American Journal of Health-System Pharmacy. 64:1174-1186
Purpose. Data collected from the Food and Drug Administration (FDA) under the Freedom of Information Act are presented to help clinicians understand the data prompting the black-box warning for droperidol and to make educated decisions regarding the
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 61(23)